BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 26484625)

  • 1. A pilot study of factors associated with glycaemic control in adults with Type 1 diabetes mellitus on insulin pump therapy.
    Wen W; Frampton R; Wright K; Fattore S; Shadbolt B; Perampalam S
    Diabet Med; 2016 Feb; 33(2):231-4. PubMed ID: 26484625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Predictive Low-Glucose Management System in Hybrid of Full Closed Loop System.
    Choudhary P
    Diabetes Technol Ther; 2016 Jul; 18(7):408-9. PubMed ID: 27379979
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes.
    Beato-Víbora P; Yeoh E; Rogers H; Hopkins D; Amiel SA; Choudhary P
    Diabet Med; 2015 Nov; 32(11):1453-9. PubMed ID: 26213236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion (CSII) therapy at Derby Teaching Hospitals: sustained benefits in glucose control.
    Anyanwagu U; Olaoye H; Jennings P; Ashton-Cleary S; Sugunendran S; Hughes D; Idris I; Wilmot EG
    Diabet Med; 2017 Aug; 34(8):1154-1157. PubMed ID: 28430381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial.
    Hermanns N; Ehrmann D; Schall S; Maier B; Haak T; Kulzer B
    Diabet Med; 2017 Aug; 34(8):1084-1091. PubMed ID: 28257159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Application of the Food Insulin Index for Mealtime Insulin Dosing in Adults with Type 1 Diabetes: A Randomized Controlled Trial.
    Bell KJ; Gray R; Munns D; Petocz P; Steil G; Howard G; Colagiuri S; Brand-Miller JC
    Diabetes Technol Ther; 2016 Apr; 18(4):218-25. PubMed ID: 26840067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cohort of children with type 1 diabetes in Greece: predictors of direct costs of care.
    Karachaliou F; Athanasakis K; Tsentidis C; Soldatou A; Simatos G; Kyriopoulos J; Michalakos S; Karavanaki K
    Pediatr Diabetes; 2017 Aug; 18(5):405-412. PubMed ID: 27444352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of socio-economic and clinical factors on HbA1c in children and adolescents with type 1 diabetes: an Italian multicentre survey.
    Gesuita R; Skrami E; Bonfanti R; Cipriano P; Ferrito L; Frongia P; Iafusco D; Iannilli A; Lombardo F; Mozzillo E; Paleari R; Rabbone I; Sabbion A; Salvatoni A; Scaramuzza A; Schiaffini R; Sulli N; Toni S; Carle F; Cherubini V
    Pediatr Diabetes; 2017 May; 18(3):241-248. PubMed ID: 26990605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.
    Brorsson AL; Viklund G; Örtqvist E; Lindholm Olinder A
    Pediatr Diabetes; 2015 Nov; 16(7):546-53. PubMed ID: 25327782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'The pump was a saviour for me.' Patients' experiences of insulin pump therapy.
    Garmo A; Hörnsten Å; Leksell J
    Diabet Med; 2013 Jun; 30(6):717-23. PubMed ID: 23398606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of deprivation, ethnicity, and insulin pump therapy on developmental trajectories of diabetes control in COB type 1 diabetes.
    Viner RM; White B; Amin R; Peters C; Khanolkar A; Christie D; Hindmarsh PC
    Pediatr Diabetes; 2017 Aug; 18(5):384-391. PubMed ID: 27534520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin regimens, diabetes knowledge, quality of life, and HbA1c in children and adolescents with type 1 diabetes.
    Keller M; Attia R; Beltrand J; Djadi-Prat J; Nguyen-Khoa T; Jay JP; Cahané M; Choleau C; Robert JJ
    Pediatr Diabetes; 2017 Aug; 18(5):340-347. PubMed ID: 27161814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.
    Aronson R; Reznik Y; Conget I; Castañeda JA; Runzis S; Lee SW; Cohen O;
    Diabetes Obes Metab; 2016 May; 18(5):500-7. PubMed ID: 26854123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suboptimal behaviour and knowledge regarding overnight glycaemia in adults with type 1 diabetes is common.
    Larsson CR; Januszewski AS; McGrath RT; Ludvigsson J; Keech AC; MacIsaac RJ; Ward GM; O'Neal DN; Fulcher GR; Jenkins AJ
    Intern Med J; 2018 Sep; 48(9):1080-1086. PubMed ID: 29573166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ISPAD Guidelines. Managing diabetes in preschool children.
    Sundberg F; Barnard K; Cato A; de Beaufort C; DiMeglio LA; Dooley G; Hershey T; Hitchcock J; Jain V; Weissberg-Benchell J; Rami-Merhar B; Smart CE; Hanas R
    Pediatr Diabetes; 2017 Nov; 18(7):499-517. PubMed ID: 28726299
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
    JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline.
    Peters AL; Ahmann AJ; Battelino T; Evert A; Hirsch IB; Murad MH; Winter WE; Wolpert H
    J Clin Endocrinol Metab; 2016 Nov; 101(11):3922-3937. PubMed ID: 27588440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
    Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
    Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study.
    Picard S; Hanaire H; Baillot-Rudoni S; Gilbert-Bonnemaison E; Not D; Reznik Y; Guerci B
    Diabetes Technol Ther; 2016 Mar; 18(3):127-35. PubMed ID: 26950530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do youth with type 1 diabetes exercise safely? A focus on patient practices and glycemic outcomes.
    Roberts AJ; Yi-Frazier JP; Aitken KE; Mitrovich CA; Pascual MF; Taplin CE
    Pediatr Diabetes; 2017 Aug; 18(5):367-375. PubMed ID: 27380934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.